Clinical Outcomes and Treatment Options in Patients With Pulmonary Hypertension Who Received Pulmonary Hypertension-Specific Drugs　- Single-Center Case Series.

Circ Rep · 2019 · PMC7892490 · PMID 33693167

Europe PMC DOI

hedged sentence

0.1540

closest p · 3.1× alpha

0.1540

boldest claim

The sentences

did not reach statistical significanceP=0.154not close (p > 0.1)

890.3±386.9 dyn∙s∙cm −5 , P=0.465, respectively), but these differences did not reach statistical significance. mRAP, mPCWP, and CO were similar between the monotherapy group and combination therapy group (mRAP: 4.5±1.9 vs. 6.7±2.4 mmHg, P=0.154; mPCWP: 10.2±5.3 vs. 9.3±4.2 mmHg, P=0.727; and CO: 3.34±0.5 vs. 3.8±1.5 L/min, P=0.497, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Clinical Outcomes and Treatment Options in Patients With Pulmonary Hypertension Who Received Pulmonary Hypertension-Specific Drugs - Single-Center Case Series.

The sentences

Clinical Outcomes and Treatment Options in Patients With Pulmonary Hypertension Who Received Pulmonary Hypertension-Specific Drugs　- Single-Center Case Series.